These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 17081685)
1. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Darvishi K; Sharma S; Bhat AK; Rai E; Bamezai RN Cancer Lett; 2007 May; 249(2):249-55. PubMed ID: 17081685 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial genetic background modifies breast cancer risk. Bai RK; Leal SM; Covarrubias D; Liu A; Wong LJ Cancer Res; 2007 May; 67(10):4687-94. PubMed ID: 17510395 [TBL] [Abstract][Full Text] [Related]
3. Germline HVR-II mitochondrial polymorphisms associated with breast cancer in Tunisian women. Yacoubi Loueslati B; Troudi W; Cherni L; Rhomdhane KB; Mota-Vieira L Genet Mol Res; 2010 Aug; 9(3):1690-700. PubMed ID: 20812191 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility. Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Elhan AH; Karakaya AE Cell Biochem Funct; 2005; 23(1):73-6. PubMed ID: 15386537 [TBL] [Abstract][Full Text] [Related]
6. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985 [TBL] [Abstract][Full Text] [Related]
7. p53 genotypes and haplotypes associated with risk of breast cancer. Buyru N; Altinisik J; Demokan S; Dalay N Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348 [TBL] [Abstract][Full Text] [Related]
8. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210 [TBL] [Abstract][Full Text] [Related]
9. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients. Gochhait S; Bhatt A; Sharma S; Singh YP; Gupta P; Bamezai RN Int J Cancer; 2008 Dec; 123(11):2580-6. PubMed ID: 18792899 [TBL] [Abstract][Full Text] [Related]
10. [Polymorphism of the mitochondrial microsatellite 303-315 in breast cancer in Tunisia]. Yacoubi-Loueslati B; Troudi W; Baccar A; Cherni L; Rhomdhane KB; Elgaaied AB Bull Cancer; 2009 Mar; 96(3):337-42. PubMed ID: 19318312 [TBL] [Abstract][Full Text] [Related]
11. Can mitochondrial DNA mutations in circulating white blood cells and serum be used to detect breast cancer? Losanoff JE; Zhu W; Qin W; Mannello F; Sauter ER Breast; 2008 Oct; 17(5):540-2. PubMed ID: 18571924 [TBL] [Abstract][Full Text] [Related]
12. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population. Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790 [TBL] [Abstract][Full Text] [Related]
13. The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. Guardado-Estrada M; Medina-Martínez I; Juárez-Torres E; Roman-Bassaure E; Macías L; Alfaro A; Alcántara-Vázquez A; Alonso P; Gomez G; Cruz-Talonia F; Serna L; Muñoz-Cortez S; Borges-Ibañez M; Espinosa A; Kofman S; Berumen J J Hum Genet; 2012 Apr; 57(4):269-76. PubMed ID: 22357541 [TBL] [Abstract][Full Text] [Related]
14. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902 [TBL] [Abstract][Full Text] [Related]
15. Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany. Wang-Gohrke S; Chang-Claude J Breast Cancer Res Treat; 2004 Dec; 88(3):231-7. PubMed ID: 15609125 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews. Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma. Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835 [TBL] [Abstract][Full Text] [Related]
18. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Wang-Gohrke S; Rebbeck TR; Besenfelder W; Kreienberg R; Runnebaum IB Anticancer Res; 1998; 18(3B):2095-9. PubMed ID: 9677474 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H. Palacín M; Alvarez V; Martín M; Díaz M; Corao AI; Alonso B; Díaz-Molina B; Lozano I; Avanzas P; Morís C; Reguero JR; Rodríguez I; López-Larrea C; Cannata-Andía J; Batalla A; Ruiz-Ortega M; Martínez-Camblor P; Coto E Mitochondrion; 2011 Jan; 11(1):176-81. PubMed ID: 20863902 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Niemi AK; Hervonen A; Hurme M; Karhunen PJ; Jylhä M; Majamaa K Hum Genet; 2003 Jan; 112(1):29-33. PubMed ID: 12483296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]